Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV

Caroline Lions1, Helene Laroche1, Olivia Zaegel-Faucher1

  • 1APHM, Hopital Sainte-Marguerite, Service d'Immuno-Hématologie Clinique.

Insights

A hepatitis C (HCV) microelimination program in an HIV clinic showed feasibility but did not achieve eradication in 12 months. HCV cure positively impacted patient health outcomes, demonstrating the value of integrated care models.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Current hepatitis C (HCV) treatment guidelines do not differentiate between HIV/HCV-coinfected and HCV-monoinfected patients.
  • A significant challenge in managing HIV-positive individuals is the lack of effective models for HCV elimination.
  • Microelimination strategies are being explored to eradicate infectious diseases within specific populations or settings.

Purpose of the Study:

  • To evaluate the feasibility of a 12-month HCV microelimination program in an HIV outpatient clinical unit.
  • To assess the possibility of eradicating HCV among people living with HIV within a defined clinical setting.
  • To investigate the impact of HCV cure on various health outcomes in coinfected patients.

Main Methods:

  • A prospective HCV microelimination program was implemented in an HIV clinic serving approximately 1000 patients.
  • The program integrated screening and direct-acting antiviral (DAA) treatment components.
  • A nested cohort study used questionnaires and statistical models to evaluate the impact of HCV cure on health.

Main Results:

  • The program diagnosed two new HCV acute infections and one reinfection among evaluated patients.
  • Of eligible patients, 46.4% initiated DAA treatment within 12 months, with 31.8% initiating after.
  • A high sustained virologic response (SVR) rate of 96.1% was achieved, with positive impacts on physical and mental health reported.

Conclusions:

  • The HCV microelimination program demonstrated feasibility at the scale of an HIV clinical unit.
  • Achieving complete HCV eradication within 12 months was not met, highlighting the need for longer-term strategies.
  • The study serves as a proof of concept for integrated HCV elimination efforts within HIV care settings.
Abstract